Clara Claudia Jap
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Clara Claudia Jap has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Henny Sri Wahyuni
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Medan, Universitas Sumatera Utara, Indonesia
2 shared publications - Gracelyn Tanaka1 shared publication
- Imam Bagus Sumantri
Department of Pharmaceutical Biology Faculty of Pharmacy Universitas Sumatera Utara 20155 Medan Indonesia
1 shared publication Marianne
1 shared publication- Nazliniwaty Nazliniwaty
Universitas Sumatera Utara
1 shared publication - Nilsya Febrika Zebua
Universitas Tjut Nyak Dhien, Sumatera Utara
1 shared publication
Latest Publications
- Open Access
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in The Open Medicinal Chemistry Journal
- Vol. 20 (1)
Targeting WEE1 Kinase with Phytochemicals from Ampelocissus thyrsiflora (Blume) Planch: An Integrated In Silico and In Vitro Study Against Human Breast Cancer Cells
Introduction: Breast cancer is the second most diagnosed cancer worldwide, with WEE1 kinase recognized as a key regulator of tumor progression. Natural products, particularly plant-derived metabolites, offer promising scaffolds for the development of novel WEE1 inhibitors. Materials and Methods: Ethanol extracts of Ampelocissus thyrsiflora (Blume) Planch, a North Sumatran endemic plant, were obtained via maceration and subjected to phytochemical screening, PASS prediction, and Lipinski’s Rule of Five evaluation. Molecular docking and 100 ns molecular dynamics (MD) simulations were performed to investigate ligand–protein interactions. Cytotoxicity was assessed using the MTT assay on MCF-7 breast cancer cells. Results: Phytochemical analysis confirmed the presence of alkaloids, flavonoids, saponins, tannins, glycosides, and steroids. Fourteen compounds exhibited strong predicted biological activity, and thirteen fulfilled drug-likeness criteria. Based on binding affinity and interactions with key WEE1 residues, four compounds were selected for MD simulations. Three demonstrated favorable MM-PBSA binding energies and stable interactions with critical residues. The ethanol extract showed an IC 50 of 2011.25 ± 42.71 µg/mL against MCF-7 cells. Discussion: The computational results highlight the potential of A. thyrsiflora metabolites as multi-target inhibitors of WEE1 kinase. Although the obtained IC 50 value is comparatively high, the result provides an important preliminary basis for subsequent investigations and potential optimization of its active constituents. Conclusion: Although the ethanol extract of A. thyrsiflora exhibited a high in vitro IC50, the in silico results provide a strong rationale for further exploration of its metabolites as potential WEE1-targeted anticancer agents.
- 27 March 2026
- Published by Bentham Science Publishers Ltd. in The Open Medicinal Chemistry Journal
- Vol. 20 (1)
Open AccessTargeting WEE1 Kinase with Phytochemicals from Ampelocissus thyrsiflora (Blume) Planch: An Integrated In Silico and In Vitro Study Against Human Breast Cancer Cells
Introduction: Breast cancer is the second most diagnosed cancer worldwide, with WEE1 kinase recognized as a key regulator of tumor progression. Natural products, particularly plant-derived metabolites, offer promising scaffolds for the development of novel WEE1 inhibitors. Materials and Methods: Ethanol extracts of Ampelocissus thyrsiflora (Blume) Planch, a North Sumatran endemic plant, were obtained via maceration and subjected to phytochemical screening, PASS prediction, and Lipinski’s Rule of Five evaluation. Molecular docking and 100 ns molecular dynamics (MD) simulations were performed to investigate ligand–protein interactions. Cytotoxicity was assessed using the MTT assay on MCF-7 breast cancer cells. Results: Phytochemical analysis confirmed the presence of alkaloids, flavonoids, saponins, tannins, glycosides, and steroids. Fourteen compounds exhibited strong predicted biological activity, and thirteen fulfilled drug-likeness criteria. Based on binding affinity and interactions with key WEE1 residues, four compounds were selected for MD simulations. Three demonstrated favorable MM-PBSA binding energies and stable interactions with critical residues. The ethanol extract showed an IC 50 of 2011.25 ± 42.71 µg/mL against MCF-7 cells. Discussion: The computational results highlight the potential of A. thyrsiflora metabolites as multi-target inhibitors of WEE1 kinase. Although the obtained IC 50 value is comparatively high, the result provides an important preliminary basis for subsequent investigations and potential optimization of its active constituents. Conclusion: Although the ethanol extract of A. thyrsiflora exhibited a high in vitro IC50, the in silico results provide a strong rationale for further exploration of its metabolites as potential WEE1-targeted anticancer agents.
- Open Access
- 9 December 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-15
Unveiling the anticancer potential of the ethanolic extract from Pometia pinnata: Molecular dynamics targeting CHK1 and cytotoxicity study on MCF-7 cells
Cancer remains one of the most lethal diseases globally, with CHK1 being a critical pathway frequently altered in cancer progression. This study evaluated the anticancer and cytotoxic properties of the ethanol extract of Matoa (Pometia pinnata) leaves in silico and in vitro. Maceration was conducted to obtain the ethanol extract with physicochemical, pharmacokinetic, and toxicity predictions conducted using Lipinski’s Rule of Five, pkCSM, and Pro-Tox II. Molecular docking was performed using Autodock Vina and DOCK6.2, followed by molecular dynamic simulations using GROMACS. Cytotoxicity assays on MCF-7 cells were carried out using the MTT methods. The results demonstrated that the extract tested positive for flavonoids, alkaloids, tannins, saponins, glycosides, and steroids. The extract also shows potential inhibitory activity against CHK1, supported by favorable binding affinities and critical amino acid interactions. Additionally, the extract exhibited a moderate cytotoxic effect on cell MCF-7 with an IC50 of 139 µg/mL.
- 9 December 2024
- Published by Pensoft Publishers in Pharmacia
- Vol. 71, 1-15
Open AccessUnveiling the anticancer potential of the ethanolic extract from Pometia pinnata: Molecular dynamics targeting CHK1 and cytotoxicity study on MCF-7 cells
Cancer remains one of the most lethal diseases globally, with CHK1 being a critical pathway frequently altered in cancer progression. This study evaluated the anticancer and cytotoxic properties of the ethanol extract of Matoa (Pometia pinnata) leaves in silico and in vitro. Maceration was conducted to obtain the ethanol extract with physicochemical, pharmacokinetic, and toxicity predictions conducted using Lipinski’s Rule of Five, pkCSM, and Pro-Tox II. Molecular docking was performed using Autodock Vina and DOCK6.2, followed by molecular dynamic simulations using GROMACS. Cytotoxicity assays on MCF-7 cells were carried out using the MTT methods. The results demonstrated that the extract tested positive for flavonoids, alkaloids, tannins, saponins, glycosides, and steroids. The extract also shows potential inhibitory activity against CHK1, supported by favorable binding affinities and critical amino acid interactions. Additionally, the extract exhibited a moderate cytotoxic effect on cell MCF-7 with an IC50 of 139 µg/mL.